Tenet expects Q4 '08 profit; FDA approves stem cell research;

> Tenet has announced that it expects to report a profit for the fourth quarter of 2008 despite the troubled economy--but won't give analysts guidance on how 2009 will go. FierceHealthFinance

> With the FDA green-lighting the first clinical trial of an embryonic stem cell therapy, stem cell researchers are cautiously optimistic that their work has entered a new era. FierceBioResearcher

> Health officials in Minnesota say that there could be a link between the shortage of Merck's Hib childhood vaccine and an increase in the incidence of that disease, which can cause meningitis and pneumonia. FierceVaccines

> A new study in the journal Pediatrics suggests that some psychotic symptoms could result from the use of medications prescribed for treatment of ADHD. Article

And Finally... Most people try to break out of jail, but this guy just had to be different. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.